DAU Library

Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial

Resource Type

ACADEMIC JOURNAL

Authors

Shi, Lei ^{a, b, 1}; Yuan, Xin ^{a, b, 1}; Yao, Weiqi ^{c, d, 1}; Wang, Siyu ^{a, 1}; Zhang, Chao ^{a, b}; Zhang, Bo ^e; Song, Jinwen ^{a, b}; Huang, Lei ^{a, b}; Xu, Zhe ^{a, b}; Fu, Jun-Liang ^{a, b}; Li, Yuanyuan ^a; Xu, Ruonan ^a; Li, Tian-Tian ^{a, f}; Dong, Jinghui ^g; Cai, Jianming ^g; Li, Genshi ^h; Xie, Yunbo ^a; Shi, Ming ^a; Li, Yonggang ^a; Zhang, Yu ^{d, i}; Xie, Wei-Fen ^{j, k, ⁎}; Wang, Fu-Sheng ^{a, b, ⁎⁎}

Source

In eBioMedicine January 2022 75

Subject

Language

English

ISSN

2352-3964

E-ISSN

DOI

10.1016/j.ebiom.2021.103789